Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.65 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.64 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.64 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.64 |
| ▸ | PTH1R | Q03431 | 2/20 | 0.53 |
| ▸ | NMUR2 | Q9GZQ4 | 3/20 | 0.50 |
| ▸ | NMUR1 | Q9HB89 | 3/20 | 0.50 |
| ▸ | VIPR1 | P32241 | 1/20 | 0.50 |
| ▸ | VIPR2 | P41587 | 1/20 | 0.50 |
| ▸ | KDM1A | O60341 | 1/20 | 0.50 |
| ▸ | GLP1R | P43220 | 2/20 | 0.49 |
| ▸ | TFPI | P10646 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30625038 | 0.96 | KEAP1 (0.62) | KEAP1MAPK8MAPK9MAPK10PTH1R | |
| SCHEMBL29376487 | 0.96 | KEAP1 (0.62) | KEAP1MAPK8MAPK9MAPK10PTH1R | |
| SCHEMBL29374226 | 0.94 | KEAP1 (0.59) | KEAP1MAPK8MAPK9MAPK10PTH1R | |
| SCHEMBL30906548 | 0.93 | KEAP1 (0.72) | KEAP1MAPK8MAPK9MAPK10PTH1R | |
| SCHEMBL29376375 | 0.92 | KEAP1 (0.60) | KEAP1MAPK8MAPK9MAPK10PTH1R | |
| SCHEMBL30624804 | 0.92 | MAPK8 (0.58) | KEAP1MAPK8MAPK9MAPK10PTH1R | |
| SCHEMBL30625028 | 0.92 | MAPK8 (0.58) | KEAP1MAPK8MAPK9MAPK10PTH1R | |
| SCHEMBL29679527 | 0.92 | MAPK8 (0.66) | KEAP1MAPK8MAPK9MAPK10PTH1R | |
| SCHEMBL30906447 | 0.92 | KEAP1 (0.66) | KEAP1MAPK8MAPK9MAPK10PTH1R | |
| SCHEMBL31688328 | 0.92 | TFPI (0.59) | KEAP1MAPK8MAPK9MAPK10NMUR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113286612-B | Humanized antibodies against IGF-I receptor | 帝人制药株式会社 | 2024-12-24 | — | — | CN | disclosed |